New study supports the safety of varenicline

A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix in the US and Champix elsewhere in the world) does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT). These findings, published in the scientific journal Addiction, confirm those of earlier clinical trials, providing further evidence of the safety of varenicline as an aid to stop smoking.
Read More

Study: Egypt, Algeria and South Africa at highest risk of importing COVID-19 cases from China

The new findings are from a modeling study published in The Lancet that estimates the preparedness (ie, health system capacity) and vulnerability (ie, demographic, environmental, socioeconomic and political conditions that could impact a country’s ability to respond) of African countries, as well as their likelihood of importing COVID-19 cases from China.
Read More

FETO therapy produces favorable outcomes when fetal and maternal care are highly coordinated

Researchers from The Johns Hopkins Center for Fetal Therapy report new evidence that fetuses with severe congenital diaphragmatic hernia, a rare but life-threatening, lung-damaging condition, experience a significantly high rate of success for the fetal treatment known as FETO, if they and their mothers receive coordinated and highly experienced care in the same expert setting.
Read More